After a product launch and simultaneous Coinbase Pro token listing, Orchid Labs’ OXT token found itself down more than 20% in value by Dec. 18, as Cointelegraph detailed in a brief. Responding to the activity, Orchid’s CEO said the business has more of a long-term focus.
“It’s obviously my responsibility as a CEO to be concerned about all aspects of the company, and given that this is now being traded, that’s one of the variables that we look at,” Orchid CEO Steven Waterhouse told Cointelegraph in a Dec. 19 interview, adding:
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.